Key result
Dexmedetomidine as an anesthetic adjunct during off-pump coronary artery bypass surgery maintained a lower heart rate (68-85 vs 85-100 beats/min) and mean arterial pressure during distal anastomoses compared to midazolam.
Why the study?
The study was conducted to evaluate the hemodynamic profile of dexmedetomidine during induction and distal coronary anastomosis in patients undergoing OPCAB compared to institutional practice using midazolam.
Does dexmedetomidine improve hemodynamic stability compared to midazolam in patients undergoing elective OPCAB surgery?
RCT (n=50)
Computer generated randomization table
No
Does dexmedetomidine improve hemodynamic stability compared to midazolam in patients undergoing elective OPCAB surgery?
Dexmedetomidine is a viable and hemodynamically stable anesthetic adjunct for patients undergoing elective off-pump coronary artery bypass surgery, effectively blunting the intubation response and maintaining lower heart rates during distal anastomosis.
Answers are grounded in this paper and cite their sources.
May offer acceptable hemodynamic control as an OPCAB adjunct; leaves open whether it improves clinical outcomes over midazolam.
Background: The aim of the present study was to study the hemodynamic profile of dexmedetomidine during induction and distal anastomosis of coronary arteries in patients undergoing OPCAB in comparison to the institutional practice of using midazolam. Methods: In Group I, (n=25) patients were anaesthetised using fentanyl, pancuronium bromide, Isoflurane and midazolam. Group II (n=25) patients received a loading dose of dexmedetomidine infusion (1µg/Kg) over 10 minutes followed by an infusion of dexmedetomidine at the rate of 0.6 µg/Kg/hour, along with fentanyl, Pancuronium bromide and isoflurane. Heart rate (HR) mean arterial pressure (MAP), pulmonary artery (PA) catheter derived data and BIS were recorded at baseline, at 1 and 3 minutes after induction, at 1, 3 and 5 minutes after intubation, and at 5 and 30 minutes after protamine administration. MAP and HR were recorded every 10 min during the operation, except during distal anastomosis of the coronary arteries when it was recorded every 5 minutes after application of the Octopus tissue stabilising system. Results: The intubation response by way of increase in HR was much less in group II and stabilized by 5 min after intubation. The accompanying hypotension at 1 minute after induction was more in group II, but it was clinically acceptable (81.68±21.74 mm Hg). During distal graft anastomoses HR was in the range of 68 beats/min to 85 beats/min in group II vs. 85 beats/min to 100 beats/min in Group I. The MAP was lower in this group during the distal anastomosis, but it was within clinically acceptable range (> 65 mm Hg). Conclusion: Dexmedetomidine is a viable option as an anaesthetic adjunct in a loading dose of 1µg/Kg followed by an infusion of 0.6 µg/Kg. Future studies will be necessary to show if this provides any outcome benefits.
No takes yet. Share an insight, caveat, or question.
Virmani et al. (2021) conducted an RCT in Coronary Artery Disease requiring Off-Pump Coronary Artery Bypass Graft (OPCAB) Surgery (n=50). Dexmedetomidine vs. Midazolam (0.02mg/Kg) was evaluated on Hemodynamic profile (Heart rate and Mean Arterial Pressure) during induction and distal anastomosis (p=<0.05). Dexmedetomidine as an anesthetic adjunct during off-pump coronary artery bypass surgery maintained a lower heart rate (68-85 vs 85-100 beats/min) and mean arterial pressure during distal anastomoses compared to midazolam.
Synapse has enriched 10 related papers. Consider them for comparative context: